Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil
- 1 July 1999
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 354 (9173) , 130-131
- https://doi.org/10.1016/s0140-6736(99)02015-2
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: Are all CMFs alike?Annals of Oncology, 1998
- Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancerThe Lancet, 1996
- Present and future projects of the international breast cancer study groupCancer, 1994